AI Science Tracker
EN

Department of Cardiology, Qinhuangdao First Hospital, Qinhuangdao, China

1 discovery from 2025

Discoveries

Machine learning-based risk prediction model development for acute kidney injury in type 2 myocardial infarction patients

Source check: Source checked. Not independent scientific confirmation.

Finding: Methods analyze 1,378 MIMIC-IV type-2 myocardial-infarction ICU patients with a held-out 30% test set; Results report AKI incidence and model discrimination. Evidence is retrospective and bounded to this cohort.

Technology: The abstract reports a held-out acute-kidney-injury risk model for a defined myocardial-infarction cohort with measured test discrimination. The Methods specify the learned operation used for this case-specific result.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
The abstract reports a held-out acute-kidney-injury risk model for a defined myocardial-infarction cohort with measured test discrimination. The Methods specify the learned operation used for this case-specific result.
Test and result
Methods analyze 1,378 MIMIC-IV type-2 myocardial-infarction ICU patients with a held-out 30% test set; Results report AKI incidence and model discrimination. Evidence is retrospective and bounded to this cohort. The source reports the cohort or measured dataset, comparison/reference and evaluation used for this specific result; conclusions remain limited to that design.
Limitation / still unknown
limited to the reported cohort or experiment.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://doi.org/10.1038/s41598-025-29404-5 · https://www.nature.com/articles/s41598-025-29404-5

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.